Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response.

  • Authors : Reimann P; Department of Internal Medicine II, Feldkirch Academic Teaching Hospital, Feldkirch, Austria.; Private University of the Principality of Liechtenstein, Triesen, Principality of Liechtenstein.

Subjects: COVID-19*/COVID-19*/COVID-19*/blood ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Immunization, Secondary*

  • Source: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (3), pp. 577-584. Date of Electronic Publication: 2021 Dec 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2.

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*blood ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology

  • Source: British journal of haematology [Br J Haematol] 2022 Jan; Vol. 196 (2), pp. 362-367. Date of Electronic Publication: 2021 Sep 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.

  • Authors : Gavriatopoulou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece.; Terpos E

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*biosynthesis ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*biosynthesis ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology

  • Source: British journal of haematology [Br J Haematol] 2022 Jan; Vol. 196 (2), pp. 356-359. Date of Electronic Publication: 2021 Sep 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study.

  • Authors : Kevličius L; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.; Hematology and Oncology Department, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.

Subjects: COVID-19* ; Hematologic Neoplasms*; Humans SARS-CoV-2 variants

  • Source: British journal of haematology [Br J Haematol] 2024 Feb; Vol. 204 (2), pp. 497-506. Date of Electronic Publication: 2023 Oct 03.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antibody and T-cell responses by ultra-deep T-cell receptor immunosequencing after COVID-19 vaccination in patients with plasma cell dyscrasias.

  • Authors : Chung A; Division of Hematology/Oncology, University of California San Francisco, San Francisco, California, USA.; Banbury B

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Paraproteinemias*; Humans

  • Source: British journal of haematology [Br J Haematol] 2022 Nov; Vol. 199 (4), pp. 520-528. Date of Electronic Publication: 2022 Aug 30.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.

  • Authors : Murray SM; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Barbanti M

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/virology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: British journal of haematology [Br J Haematol] 2022 Aug; Vol. 198 (4), pp. 668-679. Date of Electronic Publication: 2022 Jun 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers.

  • Authors : Petito E; Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.; Colonna E

Subjects: Autoimmunity* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: British journal of haematology [Br J Haematol] 2022 Jul; Vol. 198 (2), pp. 257-266. Date of Electronic Publication: 2022 May 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in patients with haematological diseases treated with anti-CD20 antibodies: An observational study.

  • Authors : Nishikubo M; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.; Shimomura Y

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Hematologic Diseases*; 2019-nCoV Vaccine mRNA-1273

  • Source: British journal of haematology [Br J Haematol] 2022 Jun; Vol. 197 (6), pp. 709-713. Date of Electronic Publication: 2022 Mar 20.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titres.

  • Authors : Šušol O; Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy; Antibodies, Viral

  • Source: British journal of haematology [Br J Haematol] 2022 May; Vol. 197 (3), pp. 302-305. Date of Electronic Publication: 2022 Feb 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.

  • Authors : Ramasamy K; Oxford University Hospitals NHS Trust, Radcliffe Department of Medicine, Oxford University, Oxford, UK.; Sadler R

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy; Adult

  • Source: British journal of haematology [Br J Haematol] 2022 May; Vol. 197 (3), pp. 293-301. Date of Electronic Publication: 2022 Feb 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×